Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Tarsus Pharmaceuticals, Inc. (TARS)
since 2020 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Tarsus Pharmaceuticals, Inc..
Table 2 shows the detailed insider transactions.
This company's CIK number is 1819790.
Total stock buying since 2020: $16,548,060.
Total stock sales since 2020: $59,553,855.
Total stock option exercises since 2020: $129,943.
Table 3. Detailed insider trading at Tarsus Pharmaceuticals, Inc. (TARS)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2026-03-20 | Neervannan Seshadri (Chief Operating Officer) | Sale | 2,989 | 66.75 | 199,515 |
| 2026-03-19 | Lin Elizabeth Yeu (Chief Medical Officer) | Sale | 390 | 67.00 | 26,130 |
| 2026-03-19 | Wahl Bryan (General Counsel) | Sale | 4,231 | 67.00 | 283,477 |
| 2026-03-19 | Whitfield Dianne C. (Chief Human Resources Officer) | Sale | 4,174 | 67.00 | 279,658 |
| 2026-03-19 | Azamian Bobak R. (President/CEO and Board Chair) | Sale | 11,964 | 67.00 | 801,588 |
| 2026-03-19 | Neervannan Seshadri (Chief Operating Officer) | Sale | 4,589 | 67.00 | 307,463 |
| 2026-03-19 | Mottiwala Aziz (Chief Commercial Officer) | Sale | 4,440 | 67.00 | 297,480 |
| 2026-03-19 | Farrow Jeffrey S (See Remarks) | Sale | 2,186 | 67.00 | 146,462 |
| 2026-03-18 | Lin Elizabeth Yeu (Chief Medical Officer) | Sale | 379 | 68.71 | 26,041 |
| 2026-03-18 | Wahl Bryan (General Counsel) | Sale | 4,125 | 68.71 | 283,428 |
| 2026-03-18 | Whitfield Dianne C. (Chief Human Resources Officer) | Sale | 4,071 | 68.71 | 279,718 |
| 2026-03-18 | Azamian Bobak R. (President/CEO and Board Chair) | Sale | 11,667 | 68.71 | 801,639 |
| 2026-03-18 | Neervannan Seshadri (Chief Operating Officer) | Sale | 3,610 | 68.71 | 248,043 |
| 2026-03-18 | Mottiwala Aziz (Chief Commercial Officer) | Sale | 4,330 | 68.71 | 297,514 |
| 2026-03-18 | Farrow Jeffrey S (See Remarks) | Sale | 2,133 | 68.71 | 146,558 |
| 2026-03-17 | Lin Elizabeth Yeu (Chief Medical Officer) | Sale | 375 | 69.42 | 26,032 |
| 2026-03-17 | Wahl Bryan (General Counsel) | Sale | 4,084 | 69.42 | 283,511 |
| 2026-03-17 | Whitfield Dianne C. (Chief Human Resources Officer) | Sale | 4,029 | 69.42 | 279,693 |
| 2026-03-17 | Azamian Bobak R. (President/CEO and Board Chair) | Sale | 10,972 | 69.42 | 761,676 |
| 2026-03-17 | Neervannan Seshadri (Chief Operating Officer) | Sale | 3,125 | 69.42 | 216,937 |
| 2026-03-17 | Mottiwala Aziz (Chief Commercial Officer) | Sale | 4,286 | 69.42 | 297,534 |
| 2026-03-17 | Farrow Jeffrey S (See Remarks) | Sale | 2,111 | 69.42 | 146,545 |
| 2026-03-16 | Link William J Phd (Director) | Sale | 12,500 | 68.96 | 861,962 |
| 2026-03-15 | Lin Elizabeth Yeu (Chief Medical Officer) | Option Ex | 2,511 | .00 | 0 |
| 2026-03-15 | Wahl Bryan (General Counsel) | Option Ex | 24,236 | .00 | 0 |
| 2026-03-15 | Whitfield Dianne C. (Chief Human Resources Officer) | Option Ex | 23,909 | .00 | 0 |
| 2026-03-15 | Azamian Bobak R. (President/CEO and Board Chair) | Option Ex | 66,274 | .00 | 0 |
| 2026-03-15 | Neervannan Seshadri (Chief Operating Officer) | Option Ex | 26,287 | .00 | 0 |
| 2026-03-15 | Mottiwala Aziz (Chief Commercial Officer) | Option Ex | 26,482 | .00 | 0 |
| 2026-03-15 | Farrow Jeffrey S (See Remarks) | Option Ex | 13,042 | .00 | 0 |
| 2026-03-04 | Neervannan Seshadri (Chief Operating Officer) | Sale | 8,366 | 76.67 | 641,421 |
| 2026-01-02 | Whitfield Dianne C. (Chief Human Resources Officer) | Sale | 15,565 | 81.41 | 1,267,115 |
| 2025-12-24 | Azamian Bobak R. (President/CEO and Board Chair) | Sale | 6,000 | 82.97 | 497,849 |
| 2025-12-16 | Lin Elizabeth Yeu (Chief Medical Officer) | Sale | 2,078 | 79.50 | 165,201 |
| 2025-12-16 | Whitfield Dianne C. (Chief Human Resources Officer) | Sale | 7,397 | 80.10 | 592,499 |
| 2025-12-15 | Goodrich Katherine (Director) | Option Ex | 2,233 | .00 | 0 |
| 2025-12-15 | Lin Elizabeth Yeu (Chief Medical Officer) | Option Ex | 6,819 | .00 | 0 |
| 2025-12-15 | Link William J Phd (Director) | Sale | 22,946 | 81.43 | 1,868,492 |
| 2025-09-24 | Azamian Bobak R. (President/CEO and Board Chair) | Sale | 6,000 | 55.37 | 332,220 |
| 2025-09-15 | Morrison Scott W (Director) | Option Ex | 1,334 | .00 | 0 |
| 2025-09-08 | Link William J Phd (Director) | Sale | 27,116 | 57.00 | 1,545,612 |
| 2025-08-11 | Azamian Bobak R. (President/CEO and Board Chair) | Sale | 6,000 | 50.00 | 300,000 |
| 2025-06-17 | Farrow Jeffrey S (See Remarks) | Sale | 13,608 | 40.42 | 550,035 |
| 2025-06-16 | Lin Elizabeth Yeu (Chief Medical Officer) | Sale | 1,006 | 41.08 | 41,326 |
| 2025-06-16 | Farrow Jeffrey S (See Remarks) | Option Ex | 27,881 | .00 | 0 |
| 2025-06-13 | Lin Elizabeth Yeu (Chief Medical Officer) | Option Ex | 3,350 | .00 | 0 |
| 2025-06-13 | Link William J Phd (Director) | Option Ex | 3,350 | .00 | 0 |
| 2025-06-09 | Mottiwala Aziz (Chief Commercial Officer) | Sale | 17,500 | 43.76 | 765,800 |
| 2025-03-24 | Azamian Bobak R. (President/CEO and Board Chair) | Sale | 6,000 | 50.00 | 300,000 |
| 2025-03-20 | Wahl Bryan (General Counsel) | Sale | 3,084 | 50.11 | 154,539 |
| 2025-03-20 | Whitfield Dianne C. (Chief Human Resources Officer) | Sale | 2,137 | 50.11 | 107,085 |
| 2025-03-20 | Azamian Bobak R. (President/CEO and Board Chair) | Sale | 8,534 | 50.11 | 427,638 |
| 2025-03-20 | Neervannan Seshadri (Chief Operating Officer) | Sale | 2,435 | 50.11 | 122,017 |
| 2025-03-20 | Mottiwala Aziz (Chief Commercial Officer) | Sale | 3,365 | 50.11 | 168,620 |
| 2025-03-20 | Farrow Jeffrey S (See Remarks) | Sale | 1,186 | 50.11 | 59,430 |
| 2025-03-19 | Wahl Bryan (General Counsel) | Sale | 3,261 | 47.40 | 154,571 |
| 2025-03-19 | Whitfield Dianne C. (Chief Human Resources Officer) | Sale | 2,259 | 47.40 | 107,076 |
| 2025-03-19 | Azamian Bobak R. (President/CEO and Board Chair) | Sale | 8,551 | 47.40 | 405,317 |
| 2025-03-19 | Neervannan Seshadri (Chief Operating Officer) | Sale | 2,543 | 47.40 | 120,538 |
| 2025-03-19 | Mottiwala Aziz (Chief Commercial Officer) | Sale | 3,557 | 47.40 | 168,601 |
| 2025-03-19 | Farrow Jeffrey S (See Remarks) | Sale | 1,254 | 47.40 | 59,439 |
| 2025-03-18 | Wahl Bryan (General Counsel) | Sale | 3,341 | 46.29 | 154,654 |
| 2025-03-18 | Whitfield Dianne C. (Chief Human Resources Officer) | Sale | 2,315 | 46.29 | 107,161 |
| 2025-03-18 | Azamian Bobak R. (President/CEO and Board Chair) | Sale | 7,131 | 46.29 | 330,093 |
| 2025-03-18 | Neervannan Seshadri (Chief Operating Officer) | Sale | 2,605 | 46.29 | 120,585 |
| 2025-03-18 | Mottiwala Aziz (Chief Commercial Officer) | Sale | 3,643 | 46.29 | 168,634 |
| 2025-03-18 | Farrow Jeffrey S (See Remarks) | Sale | 1,284 | 46.29 | 59,436 |
| 2025-03-15 | Wahl Bryan (General Counsel) | Option Ex | 19,213 | .00 | 0 |
| 2025-03-15 | Whitfield Dianne C. (Chief Human Resources Officer) | Option Ex | 18,885 | .00 | 0 |
| 2025-03-15 | Azamian Bobak R. (President/CEO and Board Chair) | Option Ex | 51,395 | .00 | 0 |
| 2025-03-15 | Neervannan Seshadri (Chief Operating Officer) | Option Ex | 21,264 | .00 | 0 |
| 2025-03-15 | Mottiwala Aziz (Chief Commercial Officer) | Option Ex | 20,957 | .00 | 0 |
| 2025-03-15 | Farrow Jeffrey S (See Remarks) | Option Ex | 8,019 | .00 | 0 |
| 2025-03-07 | Goldberg Andrew D. (Director) | Option Ex | 7,000 | 12.89 | 90,230 |
| 2024-09-15 | Morrison Scott W (Director) | Option Ex | 1,333 | .00 | 0 |
| 2024-08-12 | Link William J Phd | Sale | 35,000 | 26.27 | 919,450 |
| 2024-06-24 | Lin Elizabeth Yeu (Director) | Option Ex | 3,350 | .00 | 0 |
| 2024-06-24 | Goldberg Andrew D. (Director) | Option Ex | 3,350 | .00 | 0 |
| 2024-06-24 | Morrison Scott W (Director) | Option Ex | 3,350 | .00 | 0 |
| 2024-06-24 | Chaudhuri Bhaskar (Director) | Option Ex | 3,350 | .00 | 0 |
| 2024-06-24 | Crane Rosemary A (Director) | Option Ex | 3,350 | .00 | 0 |
| 2024-06-24 | Link William J Phd (Director) | Option Ex | 3,350 | .00 | 0 |
| 2024-06-24 | Yarno Wendy L (Director) | Option Ex | 3,350 | .00 | 0 |
| 2024-06-18 | Farrow Jeffrey S (See Remarks) | Sale | 10,445 | 27.47 | 286,924 |
| 2024-06-17 | Farrow Jeffrey S (See Remarks) | Option Ex | 27,881 | .00 | 0 |
| 2024-03-18 | Wahl Bryan (General Counsel) | Sale | 4,436 | 30.60 | 135,741 |
| 2024-03-18 | Whitfield Dianne C. (Chief Human Resources Officer) | Sale | 4,314 | 30.60 | 132,008 |
| 2024-03-18 | Azamian Bobak R. (President/CEO and Board Chair) | Sale | 10,415 | 30.60 | 318,699 |
| 2024-03-18 | Neervannan Seshadri (Chief Operating Officer) | Sale | 4,879 | 30.60 | 149,297 |
| 2024-03-18 | Mottiwala Aziz (Chief Commercial Officer) | Sale | 4,766 | 30.60 | 145,839 |
| 2024-03-15 | Wahl Bryan (General Counsel) | Option Ex | 12,038 | .00 | 0 |
| 2024-03-15 | Whitfield Dianne C. (Chief Human Resources Officer) | Option Ex | 11,711 | .00 | 0 |
| 2024-03-15 | Azamian Bobak R. (President/CEO and Board Chair) | Option Ex | 28,274 | .00 | 0 |
| 2024-03-15 | Neervannan Seshadri (Chief Operating Officer) | Option Ex | 13,245 | .00 | 0 |
| 2024-03-15 | Mottiwala Aziz (Chief Commercial Officer) | Option Ex | 12,938 | .00 | 0 |
| 2023-12-27 | Azamian Bobak R. (President/CEO and Board Chair) | Sale | 8,000 | 20.22 | 161,760 |
| 2023-12-20 | Azamian Bobak R. (President/CEO and Board Chair) | Sale | 40,000 | 20.16 | 806,400 |
| 2023-12-20 | Trevejo Jose M. (CHIEF MEDICAL OFFICER) | Sale | 2,252 | 20.00 | 45,040 |
| 2023-12-15 | Goldberg Andrew D. (Director) | Buy | 1,000 | 18.96 | 18,960 |
| 2023-12-02 | Yarno Wendy L (Director) | Option Ex | 5,000 | .00 | 0 |
| 2023-11-30 | Wahl Bryan (General Counsel) | Sale | 8,356 | 16.31 | 136,286 |
| 2023-11-30 | Whitfield Dianne C. (Chief Human Resources Officer) | Sale | 8,355 | 16.31 | 136,270 |
| 2023-11-29 | Wahl Bryan (General Counsel) | Option Ex | 23,920 | .00 | 0 |
| 2023-11-29 | Whitfield Dianne C. (Chief Human Resources Officer) | Option Ex | 23,920 | .00 | 0 |
| 2023-11-15 | Azamian Bobak R. (President/CEO and Board Chair) | Sale | 8,000 | 18.61 | 148,880 |
| 2023-10-18 | Azamian Bobak R. (President/CEO and Board Chair) | Sale | 8,000 | 13.24 | 105,920 |
| 2023-10-05 | Trevejo Jose M. (CHIEF MEDICAL OFFICER) | Sale | 1,604 | 18.00 | 28,872 |
| 2023-09-20 | Azamian Bobak R. (President/CEO and Board Chair) | Sale | 8,000 | 17.21 | 137,680 |
| 2023-09-15 | Morrison Scott W (Director) | Option Ex | 1,333 | .00 | 0 |
| 2023-08-23 | Azamian Bobak R. (President/CEO and Board Chair) | Sale | 8,000 | 17.23 | 137,840 |
| 2023-08-15 | Lin Elizabeth Yeu (Director) | Buy | 19,012 | 16.80 | 319,400 |
| 2023-07-19 | Azamian Bobak R. (President/CEO and Board Chair) | Sale | 103,900 | 19.66 | 2,042,674 |
| 2023-07-19 | Mottiwala Aziz (Chief Commercial Officer) | Sale | 2,400 | 20.05 | 48,120 |
| 2023-07-12 | Azamian Bobak R. (President/CEO and Board Chair) | Sale | 9,000 | 17.35 | 156,150 |
| 2023-06-21 | Azamian Bobak R. (President/CEO and Board Chair) | Sale | 8,000 | 18.63 | 149,040 |
| 2023-06-16 | Lin Elizabeth Yeu (Director) | Option Ex | 2,000 | .00 | 0 |
| 2023-06-16 | Goldberg Andrew D. (Director) | Option Ex | 2,000 | .00 | 0 |
| 2023-06-16 | Chaudhuri Bhaskar (Director) | Option Ex | 2,000 | .00 | 0 |
| 2023-06-16 | Crane Rosemary A (Director) | Option Ex | 2,000 | .00 | 0 |
| 2023-06-16 | Link William J Phd (Director) | Option Ex | 2,000 | .00 | 0 |
| 2023-06-16 | Yarno Wendy L (Director) | Option Ex | 2,000 | .00 | 0 |
| 2023-06-14 | Azamian Bobak R. (President/CEO and Board Chair) | Sale | 9,000 | 18.58 | 167,219 |
| 2023-06-08 | Azamian Bobak R. (President/CEO and Board Chair) | Sale | 3,100 | 20.01 | 62,031 |
| 2023-06-07 | Mottiwala Aziz (Chief Commercial Officer) | Sale | 2,500 | 19.34 | 48,350 |
| 2023-06-06 | Mottiwala Aziz (Chief Commercial Officer) | Sale | 2,143 | 18.61 | 39,881 |
| 2023-05-17 | Azamian Bobak R. (President/CEO and Board Chair) | Sale | 8,000 | 15.90 | 127,200 |
| 2023-05-10 | Azamian Bobak R. (President/CEO and Board Chair) | Sale | 9,000 | 16.80 | 151,200 |
| 2023-05-01 | Azamian Bobak R. (President/CEO and Board Chair) | Sale | 5,841 | 15.10 | 88,199 |
| 2023-04-28 | Azamian Bobak R. (President/CEO and Board Chair) | Sale | 4,278 | 15.13 | 64,726 |
| 2023-04-21 | Azamian Bobak R. (President/CEO and Board Chair) | Sale | 2,311 | 15.03 | 34,734 |
| 2023-04-20 | Greenstein Leonard M. (Chief Financial Officer) | Sale | 5,000 | 14.02 | 70,100 |
| 2023-04-19 | Azamian Bobak R. (President/CEO and Board Chair) | Sale | 8,000 | 13.60 | 108,800 |
| 2023-03-23 | Wahl Bryan (General Counsel) | Sale | 371 | 12.15 | 4,507 |
| 2023-03-23 | Whitfield Dianne C. (Chief Human Resources Officer) | Sale | 345 | 12.15 | 4,191 |
| 2023-03-23 | Azamian Bobak R. (President/CEO and Board Chair) | Sale | 737 | 12.15 | 8,954 |
| 2023-03-23 | Neervannan Seshadri (Chief Operating Officer) | Sale | 390 | 12.15 | 4,738 |
| 2023-03-23 | Mottiwala Aziz (Chief Commercial Officer) | Sale | 372 | 12.15 | 4,519 |
| 2023-03-23 | Trevejo Jose M. (CHIEF MEDICAL OFFICER) | Sale | 465 | 12.15 | 5,649 |
| 2023-03-23 | Greenstein Leonard M. (Chief Financial Officer) | Sale | 346 | 12.15 | 4,203 |
| 2023-03-22 | Wahl Bryan (General Counsel) | Sale | 357 | 12.64 | 4,512 |
| 2023-03-22 | Whitfield Dianne C. (Chief Human Resources Officer) | Sale | 333 | 12.64 | 4,209 |
| 2023-03-22 | Azamian Bobak R. (President/CEO and Board Chair) | Sale | 709 | 12.64 | 8,961 |
| 2023-03-22 | Neervannan Seshadri (Chief Operating Officer) | Sale | 379 | 12.64 | 4,790 |
| 2023-03-22 | Mottiwala Aziz (Chief Commercial Officer) | Sale | 357 | 12.64 | 4,512 |
| 2023-03-22 | Trevejo Jose M. (CHIEF MEDICAL OFFICER) | Sale | 529 | 12.64 | 6,686 |
| 2023-03-22 | Greenstein Leonard M. (Chief Financial Officer) | Sale | 332 | 12.64 | 4,196 |
| 2023-03-21 | Wahl Bryan (General Counsel) | Sale | 350 | 12.89 | 4,511 |
| 2023-03-21 | Whitfield Dianne C. (Chief Human Resources Officer) | Sale | 326 | 12.89 | 4,202 |
| 2023-03-21 | Azamian Bobak R. (President/CEO and Board Chair) | Sale | 679 | 12.89 | 8,752 |
| 2023-03-21 | Neervannan Seshadri (Chief Operating Officer) | Sale | 372 | 12.89 | 4,795 |
Insider trading activities including stock purchases, stock sales, and option exercises
of TARS listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Tarsus Pharmaceuticals, Inc. (symbol TARS,
CIK number 1819790) see
the Securities and Exchange Commission (SEC) website.